Prime Medicine, Inc.PRMENASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-130.16M
↓ 57% below average
Average (5y)
$-82.99M
Historical baseline
Range
High:$-1.33M
Low:$-174.14M
CAGR
+150.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-130.16M | +25.3% |
| 2023 | $-174.14M | -17.7% |
| 2022 | $-147.92M | -286.9% |
| 2021 | $-38.23M | -518.3% |
| 2020 | $-6.18M | -363.5% |
| 2019 | $-1.33M | - |